1. Bakshi NA, Al-Zahrani H. Bone marrow oxalosis. Blood. 2012; 120:8. PMID:
22953330.
Article
2. Taşli F, Özkök G, Ok ES, Soyer N, Mollamehmetoğlu H, Vardar E. Massive bone marrow involvement in an end stage renal failure case with erythropoietin-resistant anemia and primary hyperoxaluria. Ren Fail. 2013; 35:1167–1169. PMID:
23879652.
3. Bhasin B, Ürekli HM, Atta MG. Primary and secondary hyperoxaluria: understanding the enigma. World J Nephrol. 2015; 4:235–244. PMID:
25949937.
Article
4. Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013; 369:649–658. PMID:
23944302.
Article
5. Lorenzo V, Torres A, Salido E. Primary hyperoxaluria. Nefrologia. 2014; 34:398–412. PMID:
24798559.
6. Sud K, Swaminathan S, Varma N, Kohli HS, Jha V, Gupta KL, et al. Reversal of pancytopenia following kidney transplantation in a patient of primary hyperoxaluria with bone marrow involvement. Nephrology (Carlton). 2004; 9:422–425. PMID:
15663648.
Article
7. Bergstralh EJ, Monico CG, Lieske JC, Herges RM, Langman CB, Hoppe B, et al. Transplantation outcomes in primary hyperoxaluria. Am J Transplant. 2010; 10:2493–2501. PMID:
20849551.
Article